The National Aspergillosis Centre is part of the Manchester Fungal Infection Group (MFIG) who have just published an important paper in the very prestigious Nature Communications journal.
Sara Gago in Paul Bowyer’s lab has characterised a mutation carried by people that researchers have found make their airways stickier, thus enabling Aspergillus spores to stick and grow. The implications for infection (ABPA) are pretty clear and the group have already discovered that this mutation is common in people with ABPA (28% of patients in this study had this mutation). This leads us straight to thinking about screening out people who are prone to infection as they carry this gene mutation. We can then pay special attention to prevent them getting ABPA. What this means for people who already have ABPA is less clear, but certainly suggests another target for treatment.
Share this post
Latest News posts
World Aspergillosis Day 2020
February 3, 2020
Hope on the horizon: Novel antifungal treatments in development
January 20, 2020
How can I protect myself from air pollution?
January 17, 2020
‘Smart shirt’ used to monitor lung function
December 4, 2019
Bedding, allergies and lung health
December 2, 2019
The importance of measles vaccination
November 8, 2019
Fireworks, bonfires and aspergillosis
November 6, 2019
How people with aspergillosis can help look after their liver
October 28, 2019
A step-change in computer power for aspergillosis genomics
October 24, 2019
News archive
- Antifungals in development
- COVID-19
- Events
- Fundraising
- General interest
- How do I...?
- Information and Learning
- Latest research news
- Lifestyle and Coping Skills
- Living with Aspergillosis
- NAC announcements
- News archive
- Patient and Carer Blog
- Patient stories
- Recordings
- Supplements and complementary therapies
- Types of aspergillosis
- Video